Skip to content

Resources

Sichenzia Ross Friedman Ference LLP Advises Vuzix Corporation on a $3 Million PIPE Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Sorrento Therapeutics, Inc. on $25.0 million Public Offering of Common Stock

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Secondary Public Offering of Cyclacel Pharmaceuticals, Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Private Placement of Relmada Therapeutics, Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company, L.L.C on $ 2.5 million Private Placement of X2 Bio Systems, Inc..

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Brean Capital LLC on $ 6.5 million Registered Direct Offering of ClearSign Combustion Corporation

May 6, 2020

Cell Source

May 6, 2020

SMTP, Inc.

May 6, 2020

Be Active Holdings

May 6, 2020

Valor Gold Corp

May 6, 2020

Pegasi Energy Resources

May 6, 2020

Yappn

May 6, 2020

BitCoin Shop Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $43.5 Million Shelf Takedown

May 6, 2020

Sichenzia Ross Friedman Ference LLP Advises Xenetic Biosciences in Reverse Merger and Direct PIPE Investment.

May 6, 2020

MusclePharm Corporation

May 6, 2020

Intellicheck Mobilisa

May 6, 2020

Paulson Capital Corp

May 6, 2020

60 Days And Counting: “Regulation Best Interest” Is Nearly Here. Are Independent Broker-Dealers Ready? What They Need to Know and Do

April 29, 2020